StockData
Emergent BioSolutions Inc. logo

Emergent BioSolutions Inc. (EBS) stock

EBSNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 3, 2026Score 6/3072% below fair value
$5.79−0.10 (-1.70%)

Close on Nov 13, 2026Market cap $296.87MP/E –Yield –

Emergent BioSolutions price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Emergent BioSolutions's price to book ratio was 0.9× on Nov 11, 2026, against 1.0× a year earlier. Over the last 5 years it ranged from 0.1× to 1.7×, with a median of 0.8×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.9×−0.2
2025Dec 31, 20251.1×+0.1
2024Dec 31, 20241.0×+0.8
2023Dec 29, 20230.2×−0.2
2022Dec 30, 20220.4×−1.1
2021Dec 31, 20211.5×−2.3
2020Dec 31, 20203.8×+1.1
2019Dec 31, 20192.7×−0.4
2018Dec 31, 20183.1×+1.0
2017Apr 28, 20172.0×+0.0
2015Apr 30, 20152.0×+0.0
2014Dec 31, 20142.0×+0.2
2013Dec 31, 20131.8×+0.4
2012Dec 31, 20121.4×−0.2
2011Dec 30, 20111.6×–

More Emergent BioSolutions figures

See a number that looks wrong?